Buchang Pharmaceutical announced that on July 28, 2026, the board of directors of the company deliberated and approved the proposed foreign investment to establish a holding subsidiary Shandong Buchang Shengshi Pharmaceutical Co., Ltd., with a registered capital of 50 million yuan, and the company invested 33.5 million yuan to hold 67% of the shares. On August 5, 2026, the company and Jinan Fuju Changyuan Enterprise Management Center officially signed the “Cooperation Agreement on Shandong Buchang Shengshi Pharmaceutical Co., Ltd.”

Buchang Pharmaceutical announced that on July 28, 2026, the board of directors of the company deliberated and approved the proposed foreign investment to establish a holding subsidiary Shandong Buchang Shengshi Pharmaceutical Co., Ltd., with a registered capital of 50 million yuan, and the company invested 33.5 million yuan to hold 67% of the shares. On August 5, 2026, the company and Jinan Fuju Changyuan Enterprise Management Center officially signed the “Cooperation Agreement on Shandong Buchang Shengshi Pharmaceutical Co., Ltd.”